Irvine, CA 的 腎臟癌（腎細胞癌） 臨床試驗
7 項針對 腎臟癌（腎細胞癌） 的研究正在 Irvine（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
招募中2 期
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
招募中1/2 期
- City of Hope at Irvine Lennar, Irvine
- City of Hope Investigational Drug Services (IDS), Irvine
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
招募中3 期
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- City of Hope at Irvine Lennar, Irvine
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
招募中2 期
- City of Hope at Irvine Lennar, Irvine
Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer
招募中1 期
- City of Hope Medical Center, Irvine
Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery
招募中2 期
- City of Hope at Irvine Lennar, Irvine
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
招募中2 期
- City of Hope, Irvine
其他城市的 腎臟癌（腎細胞癌） 試驗
- Houston, TX35 項研究
- New York City, NY27 項研究
- Dallas, TX23 項研究
- Nashville, TN23 項研究
- St. Louis, MO23 項研究
- Los Angeles, CA20 項研究
- Boston, MA16 項研究
- Baldwin Park, CA16 項研究
- Pittsburgh, PA15 項研究
- Philadelphia, PA15 項研究
- Queens, NY15 項研究
- Cleveland, OH14 項研究
Irvine 的其他研究
- 非小細胞肺癌25 項研究
- 乳癌23 項研究
- 癌症（所有類型）17 項研究
- 轉移性癌症16 項研究
- 肺癌15 項研究
- 多發性骨髓瘤14 項研究
- 前列腺癌14 項研究
- 卵巢癌12 項研究
- 頭頸部鱗狀細胞癌11 項研究
- 膀胱癌11 項研究
- 阿茲海默症11 項研究
- 大腸直腸癌10 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。